Intra-Cellular Therapies, Inc. (ITCI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Intra-Cellular Therapies, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -115.34x | -49.16x | -19.42x | -14.97x | -9.86x | -12.82x |
| P/B Ratio | 7.50x | 11.61x | 7.59x | 10.18x | 3.41x | 9.71x |
| P/S Ratio | 12.65x | 14.79x | 19.98x | 52.05x | 99.31x | 31238.16x |
| Profitability | ||||||
| Gross Margin | 91.6% | 92.7% | 91.8% | 90.2% | 91.6% | -687.2% |
| Operating Margin | -17.1% | -34.3% | -105.8% | -349.6% | -1026.3% | -254090.5% |
| Net Margin | -11.0% | -30.1% | -102.9% | -347.7% | -1007.5% | -243713.7% |
| EBITDA Margin | -17.1% | -34.2% | -105.6% | -349.0% | -1023.9% | -253303.3% |
| Liquidity | ||||||
| Current Ratio | 6.36x | 5.41x | 8.87x | 8.76x | 18.75x | 6.36x |
| Quick Ratio | 6.23x | 5.31x | 8.58x | 8.61x | 18.56x | 6.36x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.03x | 0.03x | 44.75x | 0.04x | 0.12x |
YoY = year-over-year change. Source: FMP..